Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

9 Apr 2020 10:21

RNS Number : 3649J
Mandarin Oriental International Ltd
09 April 2020
 

The following announcement has been issued to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

9th April 2020 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2020.

 

The Group's performance was severely impacted by the COVID-19 pandemic, resulting in an unaudited underlying loss of some US$40 million in the first quarter. A majority of the Group's hotels are now effectively closed and, while most hotels in Asia remain open, they are experiencing single digit percentage occupancy levels.

 

The Group has taken a number of actions to manage costs and preserve cash. These include the suspension of non-essential expenses and capital expenditure, significantly reducing payroll costs through unpaid leave, furloughing, substantial voluntary salary reductions at all levels and participation in government support measures wherever possible. The payroll measures have been taken proportionate to the seniority and means of colleagues. The Directors would like to express their deep gratitude for the continuing dedication and resolve of colleagues during these difficult times.

 

It is too early to forecast the duration of the impact of COVID-19 on the business but, as a result of the substantial reduction in revenue and management fees from the Group's hotels, the underlying loss in the second quarter is expected to be larger than in the first quarter.

 

In light of the exceptional circumstances, the Directors have withdrawn their recommendation of a final dividend in respect of the 2019 financial year and the relevant resolution seeking approval for the payment of the dividend will no longer be put to shareholders at the Company's AGM on 6th May 2020.

 

The Group's balance sheet and liquidity position both remain strong and will enable it to sustain the current low levels of business activity for an extended period of time. At 31st March 2020, net debt was US$363 million compared to net debt of US$300 million at the end of 2019. Gearing was 6% of adjusted shareholders' funds. During the quarter, the Group invested US$19 million in the restoration of Mandarin Oriental Ritz, Madrid.

 

At 31st March 2020, in addition to US$229 million of cash reserves, the Group also had US$207 million in available debt facilities that are committed for four years. The Group's facilities are not subject to any cash flow covenants.

 

While the Group's operations are currently being dramatically impacted by events associated with the COVID-19 pandemic, Mandarin Oriental remains a powerful brand that is well positioned to benefit over the long-term, when demand for luxury travel returns.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley (852) 2895 9288

Craig Beattie (852) 2895 9288

Brunswick Group Limited

David Ashton (852) 3512 5063

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCKKLBBBZLFBBV
Date   Source Headline
10th May 202311:44 amRNSDirector/PDMR Shareholding
4th May 20231:27 pmRNSAdditional Listing
4th May 20231:14 pmRNSResult of AGM
3rd May 202311:54 amRNSTransaction in Own Shares
28th Apr 202310:59 amRNSTotal Voting Rights
28th Apr 202310:50 amRNSJC&C Interim Management Statement
28th Apr 202310:23 amRNSPT Hero Supermarket Tbk Three Months 2023 Results
26th Apr 202311:30 amRNSTransaction in Own Shares
26th Apr 202310:36 amRNSDividend
24th Apr 202311:54 amRNSTransaction in Own Shares
21st Apr 202311:41 amRNSDirector/PDMR Shareholding
21st Apr 202311:10 amRNSDividend
20th Apr 202311:41 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSPT Astra 2023 First Quarter Financial Statements
18th Apr 202312:14 pmRNSTransaction in Own Shares
17th Apr 202310:26 amRNSDirectorate Change
3rd Apr 202311:24 amRNSTransaction in Own Shares
3rd Apr 202310:25 amRNSAnnual Financial Report
31st Mar 202311:15 amRNSTotal Voting Rights
30th Mar 202311:50 amRNSTransaction in Own Shares
29th Mar 202310:24 amRNSCirc re. Scrip Dividend Scheme
27th Mar 202310:34 amRNSBlock listing Interim Review
17th Mar 20239:28 amRNSPT Hero Supermarket Tbk Full Year 2022 Results
14th Mar 202310:33 amRNSTransaction in Own Shares
14th Mar 20239:26 amRNSDirector/PDMR Shareholding
2nd Mar 202312:38 pmRNSAudit Committee Membership Change
2nd Mar 202312:20 pmRNSJMH - 2022 Preliminary Results
2nd Mar 202311:20 amRNSHKLH - 2022 Preliminary Results
2nd Mar 20239:53 amRNSDairy Farm Intl - 2022 Preliminary Results
2nd Mar 20239:30 amRNSMandarin Oriental - 2022 Preliminary Results
28th Feb 202310:10 amRNSJC&C - 2022 FY Results and Dividend
27th Feb 202312:17 pmRNSPT Astra – 2022 Full Year Financial Statements
31st Jan 202310:05 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20233:17 pmRNSDirector/PDMR Shareholding
13th Jan 202310:29 amRNSTransaction in Own Shares
30th Nov 202211:15 amRNSTotal Voting Rights
21st Nov 202210:55 amRNSTransaction in Own Shares
18th Nov 202211:15 amRNSTransaction in Own Shares
16th Nov 202211:27 amRNSTransaction in Own Shares
15th Nov 202210:37 amRNSTransaction in Own Shares
10th Nov 20229:47 amRNSInterim Management Statement
10th Nov 20229:42 amRNSInterim Management Statement
10th Nov 20229:40 amRNSInterim Management Statement
10th Nov 20229:37 amRNSInterim Management Statement
9th Nov 20229:34 amRNSJC&C Interim Management Statement
8th Nov 20229:31 amRNSCorrection: Director/PDMR Shareholding
7th Nov 202210:53 amRNSDirector/PDMR Shareholding
31st Oct 202210:39 amRNSTotal Voting Rights
31st Oct 202210:37 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.